Brain (and spinal cord) tumours
Results
Phase 3
This trial compared temozolomide (Temodal) with PCV for a type of brain tumour called glioma. This trial was open to people whose glioma had come back after treatment. This trial was supported by Cancer Research UK.
Recruitment start: 18 April 2003
Recruitment end: 4 January 2008
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Michael Brada Professor Siow-Ming Lee
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Medical Research Council (MRC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/01/010.
Last reviewed: 29 June 2014
CRUK internal database number: 4